Quality of life in adult patients with Familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: A study evaluating the effect of disease severity and country of residence

Rheumatology International

Volumn 33, Issue 7, 2013, Pages 1713-1719

  Giese, Arnd ^a   Kurucay, Mustafa ^a   Kilic, Levent ^b   Örnek, Ahmet ^a   Şendur, Süleyman Nahit ^b   Lainka, Elke ^c,d   Henning, Bernhard Ferdinand ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d AID NET Autoinflammatory Disorders (AID) in Children: Genetics Disease Mechanisms Diagnostic Marke   (Germany)

Author keywords

Adult; Familial Mediterranean fever; Germany; Quality of life; Severity of illness index; Turkey

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; EDUCATIONAL STATUS; ERYTHROCYTE SEDIMENTATION RATE; ETHNICITY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; ONSET AGE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SEX RATIO; TURKEY (REPUBLIC); WORLD HEALTH ORGANISATION QUALITY OF LIFE SCALE;

ADOLESCENT; ADULT; AGE OF ONSET; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLCHICINE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GERMANY; HEALTH STATUS; HUMANS; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TIME-TO-TREATMENT; TURKEY; YOUNG ADULT;

EID: 84879689514     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2622-y     Document Type: Article

References (23)

1. Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659-664
2. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of Familial Mediterranean fever. Arthr Rheum 40(10):1879-1885
3. Consortium TIF (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause Familial Mediterranean fever. Cell 90:797-807
4. Consortium FF (1997) A candidate gene for Familial Mediterranean fever. Nat Genet 17(1):25-31
5. Chae J, Wood G, Masters S, Richard K, Park G, Smith B, Kastner D (2006) The B30.2 domain of pyrin, the Familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 103(26):9982-9987
6. Livneh A, Langevitz P (2000) Diagnostic and treatment concerns in Familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol 14(3):477-498. doi: 10.1053/berh.2000.0089
7. Gafni J, Ravid M, Sohar E (1968) The role of amyloidosis in Familial Mediterranean fever. A population study. Isr J Med Sci 4(5):995-999
8. Buskila D, Zaks N, Neumann L, Livneh A, Greenberg S, Pras M, Langevitz P (1997) Quality of life of patients with Familial Mediterranean fever. Clin Exp Rheumatol 15(4):355-360
9. Aksentievitz I, Kastner D, Consortium TIF (1997) Microsatellite haplotypes and MEFV mutations: exploring the genealogy of FMF. In: Sohar E, Gafni J, Pras M (eds) 1st international conference on FMF, Jerusalem, 1997. Freund, Tel Aviv, pp 246-251
10. İçduygu A, Sert D (2009) Country profile Turkey. Hamburg Institute of International Economics. http://focus-migration.hwwi.de/uploads/tx- wilpubdb/CP-05-Turkey-2009.pdf Accessed 16 Mar 2012
11. Manco U (2008) Turks in Europe: from a garbled image to the complexity of migrant social reality. http://www.flw.ugent.be/cie/umanco/umanco5.htm. Accessed 16 Mar 2012
12. Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, Yalçinkaya F, Ozen S, Majeed H, Ozdogan H, Kastner D, Booth D, Ben-Chetrit E, Pugnère D, Michelon C, Séguret F, Gershoni-Baruch R, Fever ISGfP-GCiFM (2007) Country as the primary risk factor for renal amyloidosis in Familial Mediterranean fever. Arthr Rheum 56(5):1706-1712
13. Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T (2008) Disease severity in children and adolescents with Familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 68:246-248
14. The WHOQOL Group (1998) Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 28(3):551-558
15. Pras E, Livneh A, Balow JE Jr, Kastner DL, Pras M, Langevitz P (1998) Clinical differences between North African and Iraqi Jews with Familial Mediterranean fever. Am J Med Genet 75(2):216-219
16. Plebani M, De Toni S, Sanzari MC, Bernardi D, Stockreiter E (1998) The TEST 1 automated system: a new method for measuring the erythrocyte sedimentation rate. Am J Clin Pathol 110(3):334-340
17. Inal V, Kitapcioglu G, Karabulut G, Keser G, Kabasakal Y (2010) Evaluation of quality of life in relation to anxiety and depression in primary Sjogren's syndrome. Mod Rheumatol 20(6):588-597. doi: 10.1007/s10165-010-0329-z
18. Akvardar Y, Akdede BB, Ozerdem A, Eser E, Topkaya S, Alptekin K (2006) Assessment of quality of life with the WHOQOL-BREF in a group of Turkish psychiatric patients compared with diabetic and healthy subjects. Psychiatr Clin Neurosci 60(6):693-699. doi: 10.1111/j.1440-1819.2006.01584.x
19. Eser E, Fidaner H, Fidaner C (1999) Psychometric properties of the WHOQOL-100 and WHOQOL-BREF. 3P Dergisi 7(ek 2):23-40
20. Neumann L, Buskila D (1997) Measuring the quality of life of women with fibromyalgia: a Hebrew version of the quality of life scale. J Musculoskelet Pain 5(1):5-17
21. Flanagan J (1978) A research approach to improving our quality of life. Am Psychol 33(2):138-147
22. Burckhardt C, Anderson K (2003) The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes 1:60
23. Mor A, Shinar Y, Zaks N, Langevitz P, Chetrit A, Shtrasburg S, Rabinovitz E, Livneh A (2005) Evaluation of disease severity in Familial Mediterranean fever. Semin Arthr Rheum 35(1):57-64